These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al. Park JK Arthritis Rheum; 2011 Dec; 63(12):4033; author reply 4033-4. PubMed ID: 21882169 [No Abstract] [Full Text] [Related]
3. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Lübbers J; Brink M; van de Stadt LA; Vosslamber S; Wesseling JG; van Schaardenburg D; Rantapää-Dahlqvist S; Verweij CL Ann Rheum Dis; 2013 May; 72(5):776-80. PubMed ID: 23434571 [TBL] [Abstract][Full Text] [Related]
4. Reply: To PMID 24591094. Sanayama Y; Ikeda K; Yamagata M; Furuta S; Ohara O; Nakajima H Arthritis Rheumatol; 2014 Dec; 66(12):3524-5. PubMed ID: 25168697 [No Abstract] [Full Text] [Related]
5. A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients. Shiozawa S; Chihara K; Shiozawa K; Fujita T; Ikegami H; Koyama S; Kurimoto M Clin Exp Immunol; 1986 Oct; 66(1):77-87. PubMed ID: 3802576 [TBL] [Abstract][Full Text] [Related]
6. An immunoradiometric assay of serum interferon using a monoclonal antibody. Walker JR; Nagington J; Scott GM; Secher DS J Gen Virol; 1982 Sep; 62 (Pt 1)():181-5. PubMed ID: 7130951 [TBL] [Abstract][Full Text] [Related]
7. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis. Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393 [TBL] [Abstract][Full Text] [Related]
8. Detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients. Minagawa T; Mizuno K; Hirano S; Asano M; Numata A; Kohanawa M; Nakane A; Hachimori K; Tamagawa S; Negishi M Life Sci; 1989; 45(11):iii-vii. PubMed ID: 2796591 [TBL] [Abstract][Full Text] [Related]
9. Identifying biomarkers: where is the scientific methodology? Comment on the article by Sanayama et Al. Yazici Y Arthritis Rheumatol; 2014 Dec; 66(12):3524. PubMed ID: 25168756 [No Abstract] [Full Text] [Related]
10. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Thurlings RM; Boumans M; Tekstra J; van Roon JA; Vos K; van Westing DM; van Baarsen LG; Bos C; Kirou KA; Gerlag DM; Crow MK; Bijlsma JW; Verweij CL; Tak PP Arthritis Rheum; 2010 Dec; 62(12):3607-14. PubMed ID: 20722020 [TBL] [Abstract][Full Text] [Related]
11. [Interleukin-2 soluble receptors and rheumatoid arthritis]. Wendling D; Racadot E Rev Rhum Mal Osteoartic; 1991 May; 58(5):375-7. PubMed ID: 2057728 [No Abstract] [Full Text] [Related]
12. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Hopkins SJ; Meager A Clin Exp Immunol; 1988 Jul; 73(1):88-92. PubMed ID: 2458872 [TBL] [Abstract][Full Text] [Related]
13. Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray. Sanayama Y; Ikeda K; Saito Y; Kagami S; Yamagata M; Furuta S; Kashiwakuma D; Iwamoto I; Umibe T; Nawata Y; Matsumura R; Sugiyama T; Sueishi M; Hiraguri M; Nonaka K; Ohara O; Nakajima H Arthritis Rheumatol; 2014 Jun; 66(6):1421-31. PubMed ID: 24591094 [TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay. Damgaard D; Palarasah Y; Skjødt K; Catrina AI; Hensen SM; Pruijn GJ; Nielsen CH J Immunol Methods; 2014 Mar; 405():15-22. PubMed ID: 24384061 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of circulating alpha-interferon with reference to aging and osteoporosis. Shiozawa S; Tanaka Y; Morimoto I; Miyauchi A; Yamatani T; Fujita T Gerontology; 1989; 35(5-6):305-10. PubMed ID: 2630385 [TBL] [Abstract][Full Text] [Related]
16. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy]. Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258 [TBL] [Abstract][Full Text] [Related]
17. Anti-citrulline antibodies in psoriatic patients with and without arthritis. Parodi A; Drosera M; Seriolo B; Barbieri L; Rebora A Acta Derm Venereol; 2005; 85(3):253-4. PubMed ID: 16040413 [No Abstract] [Full Text] [Related]
18. [The new serological markers of rheumatoid arthritis]. Tuchocka-Piotrowska A; Puszczewicz M Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699 [TBL] [Abstract][Full Text] [Related]